
Medical tech firm MeMed nabs $93m investment to decode body’s immune responses
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQdE8zMGc5eG93enRuX1NoeGV5VmREUmhoRFIySjZONVFYY0t3T2o1N2VXbWZiUGotT0h2Nnl2bU1ZSlZqUHlkQkpSQ1hxQkRMUHQ5OEFZcXJiNEV5VnZKZmUwS1dTZms1WlVfblN3QVI4WVV4OGhza0NVVHVmeGJsX0FJQndhUXhxV28yVDkwS1BTZEQ0RGJiX0ZjZnRwWndQVlJJTHdUcEhHbFHSAbABQVVfeXFMTmdGREV6ajZCdGMwbUR6ODZmai11M1FlZTRLVWIycy1PRDBjbmdIMlliYVRIenJXZXhIX2dhQzE4Z1lpU2NZaEd1VTFjbTNJSTE1WEJhc2NpNXFOaUo5QkdBeS0xRU1ONWJOcnQ4TVhLMzI1a01PdFU2Ml9tcFozR3Y4Z1RPdzdKeTdhNktxU0lJT08wam5TMG9jZzhJU3NJTF9YRFlZbmNLT0taTC10U0k?oc=5" target="_blank">Medical tech firm MeMed nabs $93m investment to decode body’s immune responses</a>&nbsp;&nbsp;<font color="#6f6f6f">The Times of Israel</font>
